...
首页> 外文期刊>Ultrasound in Medicine and Biology >Effect of shell type on the in vivo backscatter from polymer-encapsulated microbubbles.
【24h】

Effect of shell type on the in vivo backscatter from polymer-encapsulated microbubbles.

机译:壳类型对聚合物包裹的微泡在体内向后散射的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study compared in vivo enhancement from four different polymer-encapsulated ultrasound (US) contrast agents. The agents were produced with a rigid shell composed of the biodegradable block copolymer poly[d,l-lactide-co-glycolide] (PLGA) with the lactic and glycolic acid ratios 50:50, 75:25, 85:15 and 100:0 (i.e., increasingly hydrophobic shell compositions). Approximately the same bubble diameter (1.2 mum) and concentration (0.4 g/mL) were obtained for each agent. In four rabbits, audio Doppler signals were acquired from a 10 MHz cuff transducer placed around a surgically exposed vessel (contrast dose: 0.0125 to 0.15 mL/kg). In vivo dose responses were calculated off-line (in dB). Nine rabbit kidneys were imaged during contrast administration (0.1 mL/kg) in power Doppler and grey-scale pulse inversion harmonic (PIHI) modes using an HDI 5000 scanner (Philips Medical Systems, Bothell, WA). Time-intensity curves were produced and the time-to-peak, peak intensity, slope, area under the curve (AUC) andtotal duration of enhancement for each agent were compared. All agents produced marked Doppler enhancement with increasing duration from the 50:50 agent (48 +/- 10 s) to the 75:25 agent (166 +/- 46 s), the 85:15 agent (403 +/- 83 s) and with the 100:0 agent (603 +/- 93 s) lasting longest (p < 0.02). No other parameters changed significantly, except the AUC of the 85:15 agent, which was greater than that of the 50:50 agent (190.75 vs. 61.58; p = 0.02). The in vivo dose-response curves were similar for all agents, with mean enhancement up to 20.6 +/- 1.11 dB (p = 0.17). In conclusion, contrast duration increases by an order of magnitude as the lactic acid component in the polymer-encapsulated bubbles increases and the shell, thus, becomes increasingly hydrophobic. (E-mail: ).
机译:这项研究比较了四种不同的聚合物包裹超声(US)造影剂的体内增强作用。用具有刚性壳的试剂制备,该刚性壳由可生物降解的嵌段共聚物聚[d,l-丙交酯-乙交酯乙交酯](PLGA)组成,乳酸和乙醇酸的比例为50:50、75:25、85:15和100: 0(即,越来越多的疏水性壳组成)。每种试剂的气泡直径(1.2毫米)和浓度(0.4克/毫升)大致相同。在四只兔子中,从放置在外科手术暴露血管周围的10 MHz袖带换能器中获取了音频多普勒信号(对比剂量:0.0125至0.15 mL / kg)。离线计算体内剂量反应(以dB为单位)。使用HDI 5000扫描仪(Philips Medical Systems,Bothell,WA),以功率多普勒和灰度脉冲反转谐波(PIHI)模式在造影剂给药期间(0.1 mL / kg)对九只兔肾脏成像。绘制了时间强度曲线,并比较了每种药剂的峰均时间,峰强度,斜率,曲线下面积(AUC)和增强的总持续时间。从50:50药剂(48 +/- 10 s)到75:25药剂(166 +/- 46 s),85:15药剂(403 +/- 83 s)持续时间增加,所有药剂均产生明显的多普勒增强),并且100:0代理(603 +/- 93 s)持续时间最长(p <0.02)。除了85:15剂的AUC大于50:50剂的AUC(190.75与61.58; p = 0.02)相比,其他参数没有显着变化。所有药物的体内剂量反应曲线均相似,平均增强至20.6 +/- 1.11 dB(p = 0.17)。总之,随着聚合物包封的气泡中乳酸成分的增加,造影剂的持续时间增加了一个数量级,因此外壳变得越来越疏水。 (电子邮件:)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号